查看文章

1. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584: 430–436. 2. Glenn DA, Hegde A, Kotzen E, et al. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease [e-pub ahead of print]. Kidney Int Rep. https://doi. org/10.1016/j. ekir. 2021.02. 011. Accessed March 17, 2021.

3. Voysey M, Clemens SAC, Madhi SA, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021; 397: 881–891. 4. Prendecki M, Clarke C, Brown J, et al. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 2021; 397: 1178–1181. 5. Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose …